Register entry
- Registered sites
- 0
- Active NDC listings
- 23
- Labeller names
- 2
- Live patents
- 38
- Countries
- 0
Catalogue
Drug listings by form and route
2323 active NDC listings: 14 human prescription drug, 9 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 9, BLA 8, NDA 6.
| Dosage form | NDCs |
|---|---|
| injection, solution | 7 |
| tablet | 6 |
| tablet, film coated | 4 |
| injection, powder, lyophilized, for solution | 3 |
| capsule, extended release | 2 |
| kit | 1 |
| Route | NDCs |
|---|---|
| intravenous | 6 |
| subcutaneous | 4 |
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| cephalon, llc | 19 |
| cephalon, inc. | 4 |
Exclusivity
Patents and exclusivities
38| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7862832 | FENTORAfentanyl citrate | product | Jun 2028 |
| 7862833 | FENTORAfentanyl citrate | product | Jun 2028 |
| 8445524 | TREANDAbendamustine hydrochloride | substance, product | Mar 2029 |
| 8669279 | TREANDAbendamustine hydrochloride | product | Mar 2029 |
| 8883836 | TREANDAbendamustine hydrochloride | product | Mar 2029 |
| 9533955 | TREANDAbendamustine hydrochloride | product | Mar 2029 |
| 8344006 | TREANDAbendamustine hydrochloride | product | Sept 2029 |
| 8445524*PED | TREANDAbendamustine hydrochloride | use | Sept 2029 |
| 8669279*PED | TREANDAbendamustine hydrochloride | use | Sept 2029 |
| 8883836*PED | TREANDAbendamustine hydrochloride | use | Sept 2029 |
| 9533955*PED | TREANDAbendamustine hydrochloride | use | Sept 2029 |
| 8344006*PED | TREANDAbendamustine hydrochloride | use | Mar 2030 |
| 8436190 | TREANDAbendamustine hydrochloride | product | Oct 2030 |
| 8436190*PED | TREANDAbendamustine hydrochloride | use | Apr 2031 |
Catalogue
Marketed products
23| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AMRIX | Cyclobenzaprine Hydrochloride | capsule, extended release, oral | 63459-700NDA |
| AMRIX | Cyclobenzaprine Hydrochloride | capsule, extended release, oral | 63459-701NDA |
| GRANIX | tbo-filgrastim | injection, solution, subcutaneous | 63459-910BLA |
| GRANIX | tbo-filgrastim | injection, solution, subcutaneous | 63459-912BLA |
| GRANIX | tbo-filgrastim | injection, solution, subcutaneous | 63459-918BLA |
| GRANIX | tbo-filgrastim | injection, solution, subcutaneous | 63459-920BLA |
| HERZUMA | TRASTUZUMAB | injection, powder, lyophilized, for solution, intravenous | 63459-303BLA |
| HERZUMA | TRASTUZUMAB | kit | 63459-305BLA |
| - | Modafinil | tablet | 63459-101DRUG FOR FURTHER PROCESSING |
| Provigil | Modafinil | tablet, oral | 63459-201NDA |
| TREANDA | Bendamustine Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 63459-390NDA |
| TREANDA | Bendamustine Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 63459-391NDA |
| - | Tiagabine Hydrochloride | tablet, film coated | 63459-402DRUG FOR FURTHER PROCESSING |
| - | Tiagabine Hydrochloride | tablet, film coated | 63459-404DRUG FOR FURTHER PROCESSING |
| - | Tiagabine Hydrochloride | tablet, film coated | 63459-412DRUG FOR FURTHER PROCESSING |
| - | Tiagabine hydrochloride | tablet, film coated | 63459-416DRUG FOR FURTHER PROCESSING |
| Trisenox | Arsenic Trioxide | injection, solution, intravenous | 63459-601NDA |
| Truxima | rituximab-abbs | injection, solution, intravenous | 63459-103BLA |
| Truxima | rituximab-abbs | injection, solution, intravenous | 63459-104BLA |
| - | armodafinil | tablet | 63459-205DRUG FOR FURTHER PROCESSING |
| - | armodafinil | tablet | 63459-215DRUG FOR FURTHER PROCESSING |
| - | armodafinil | tablet | 63459-220DRUG FOR FURTHER PROCESSING |
| - | armodafinil | tablet | 63459-225DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing armodafinil
- Patheon Manufacturing Services LLC19 sites · 319 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Mylan Pharmaceuticals, Inc.0 sites · 489 NDC
Enquiry
Common questions
- Is Cephalon, Inc. FDA approved?
- Cephalon, Inc. holds no registered establishment of its own; 23 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Cephalon, Inc. make?
- 23 products are listed under Cephalon, Inc. in the openFDA NDC Directory, most often as injection, solution; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.